Clinical Trials Directory

Trials / Unknown

UnknownNCT06334224

Acute Physiological Responses to Twice Daily Blood Flow Restriction Training

Effects of Twice Daily Blood Flow Restriction Training on Muscle Swelling, Markers of Exercise Induced Muscle Damage and Inflammation: A Randomised Control Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
18 (estimated)
Sponsor
Defence Medical Rehabilitation Centre, UK · Other Government
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The Academic Department of Military Rehabilitation (ADMR) is currently conducting a pan-defence, randomised control trial (RCT) investigating the utility of twice daily blood flow restriction training in UK military personnel with persistent knee pain (NCT05719922). Due to logistical confinements, this pan-defence RCT is confined to collecting outcome data pre and post-intervention. Therefore, the acute physiological mechanisms which underpin adaptation will remain unknown. Consequently, ADMR is undertaking an additional, single centre RCT which will compare the acute physiological responses to low load resistance training with and without the addition of blood flow restriction. Specifically, this study will elucidate the effect of twice daily blood flow restriction training on measures of muscle swelling, muscle damage and inflammation. This data may aid in the optimisation of blood flow restriction exercise prescription within UK Defence Rehabilitation and elsewhere.

Conditions

Interventions

TypeNameDescription
DEVICELow load resistance training with blood flow restrictionThe intervention involves placing a pneumatic tourniquet system over the proximal thigh. The cuff is inflated to 80% of limb occlusion pressure during lower limb strengthening exercises. These exercises include leg press and knee extensor exercises. Four sets (30,15,15,15 repetitions) performed at 20% of one repetition maximum.
OTHERLow load resistance trainingLeg press and knee extensor exercises. Four sets (30,15,15,15 repetitions) performed at 20% of one repetition maximum.

Timeline

Start date
2023-11-06
Primary completion
2024-09-01
Completion
2024-09-01
First posted
2024-03-27
Last updated
2024-03-27

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06334224. Inclusion in this directory is not an endorsement.